A BRIEF REVIEW ON TREATMENTS OF ALZHEIMER DISEASES
Journal Title: Asian Journal Of Pharmaceutical Research and Development - Year 2017, Vol 5, Issue 2
Abstract
Alzheimer disease is the most common form of the dementia which occurs among older people above the age of 60years. The Alzheimer’s disease once considered a rare disorder and it is now seen as a major public health problem that is seriously affecting millions of older people and their families world over. Alzheimer's is characterized by massive loss of neurons and disrupted signaling between cells in the brain. The disease can be diagnosed post mortem by observing tangles inside and senile plaques outside cells throughout the brain. The first neurotransmitter defect discovered in Alzheimer disease involved acetylcholine (ACh). As cholinergic function is required for short term memory.Traditionally herbal drugs have been used to enhance cognitive functions andto alleviate other functions associate with the AD. A number of medicinal plants per se and medicines derived from these plants have shown memory enhancing properties by virtue of their medicinal constituents. One of the mechanisms suggested to dementia is decreased cholinergic activity in brain.The studies related to clinical trials of drugs in patients with Alzheimer disease have focused on the development of drugs augmenting the level of neurotransmitter acetylcholine in the brain in order to compensate for the loss of cholinergic function. Amongst these drugs, acetylcholine precursors, muscarinic agonists, nicotinic agonists and choline esterase inhibitors have extensively been studied in patients with Alzheimer’s disease and the successful approach to treat this disease have employed acetylcholineesterase (AChE) inhibition. The clinical response of few drugs namely donepezil (Aricept), rivastigmine (Exelon), galantamine (Reminyl) and Memantine (Nemenda) approved by Food and Drug Alzheimer disease ministration (FDA).
Authors and Affiliations
Amit Kumar Viswas
Keywords
Related Articles
- EP ID EP303198
- DOI -
- Views 171
- Downloads 0
EFFECT OF RED BETEL (PIPER CROCATUM RUIZ AND PAV.) ETHANOL EXTRACT AGAINST CARBON TETRACHLORIDE INDUCE HEPATIC INJURY IN RATS
Hepatic disorder is one of a big problem in health system especially cirrhosis. Based on WHO, the prevalence of cirrhosis is 1,3% and 18th caused death about 800.000 cases. Herbal medicines are widely used in treatment a...
DEVELOPMENT AND OPTIMIZATION OF IMMEDIATE RELEASE TABLET OF FEBUXOSTAT IN GOUT TREATMENT
The Formulated Immediate Release tablet based was established by wet granulation techniques. The Optimized tablet were film coated for taste masking of unpleasant taste of Febuxostat drug to impro...
Liquisolid Technology: A Novel Concept
Most of the drugs that have been invented are BCS Class II. This technique of delivering drugs is suitable mostly for lipophilic drugs and poorly water soluble drugs and enhance the immediate or sustain release formulati...
QUALITY RISK MANAGEMENT – CAPA TO PREVENT POTENTIAL QUALITY ISSUES
In the pharmaceutical industry there are number of risks and failure involved in each and every pharmaceutical product throughout the life cycle. Risk are managed in our day to day life and ensure that preventive measure...
REGULATORY ASPECTS OF CLEANING AND CLEANING VALIDATION IN ACTIVE PHARMACEUTICAL INGREDIENTS
Pharmaceutical product and active pharmaceutical ingredients (APIs) can be contaminated by other pharmaceutical products or APIs, by cleaning agents, by microorganisms or by other materials e.g....